Fujifilm Medical Systems U.S.A. provides diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities.
The introduction of the new unit marks the company’s entry into the US computed tomography market.
FCT Embrace is optimized for both oncology and radiology applications. When combined with other oncology solutions, it can offer enhanced and efficient CT Simulation with radiotherapy treatment planning capabilities.
Introduction of this product expands the end-to-end diagnostic imaging product portfolio which is known for its high imaging quality at low dose.
According to the Japanese company, FCT Embrace offers high quality imaging capabilities on an easy-to-use, standardized platform for both radiology and oncology.
The new system has been designed to improve accuracy throughout the entire oncology care cycle.
The bore matches the rotational arc of the linear accelerator, offering precise positioning options for simulation and treatment planning. This design allows oncology patients to be imaged in their optimal treatment position at the full clinical image quality afforded by 64 slice or greater systems for the first time, while maintaining the accuracy requirements, the radiation oncology demands without compromising diagnostic image quality.
Fujifilm Medical Systems U.S.A chief operating officer Johann Fernando said: “Fujifilm is a company of ‘firsts’ in diagnostic imaging. In 1936, we took our first steps in the development of X-ray film; and in 1983, we pioneered the first digitized radiography system in the world.
“Once again we are innovating with the launch of the FCT Embrace, a solution that provides the most slices ever seen on an 85cm bore system. Designed to improve radiation oncology care, this advanced solution boosts patient comfort and security by offering the widest tabletop currently available at 49cm, and accommodating bariatric patients of up to 660lbs.”
